5.15 HIV and non-tuberculous mycobacterial infection

Jennifer F. Hoy, Deborah Marriott, Tom Gottlieb

Research output: Contribution to journalArticleResearchpeer-review


About one in three patients with advanced immune deficiency will develop disseminated MAC infection. This incidence can be reduced with prophylactic drug therapy, and established infections can be effectively treated, with improved quality of life and lengthened survival.

Original languageEnglish
Pages (from-to)543-545
Number of pages3
JournalThe Medical Journal of Australia
Issue number9
Publication statusPublished - 6 May 1996

Cite this